Two Sigma Securities’s Entera Bio ENTX Stock Holding History

Two Sigma Securities’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,554	Closed	-$21.3K	–	1648
2025 Q1	$21.3K	Buy	+12,554	New	+$27.3K	﹤0.01%	1090
2024 Q1	–	Sell	-69,441	Closed	-$41.7K	–	3119
2023 Q4	$41.7K	Buy	+69,441	New	+$47.4K	﹤0.01%	2631

Other funds holding ENTX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SEIA

Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Two Sigma Securities's ENTX Position: Q2 2025 in Review

Two Sigma Securities sold out of Entera Bio (ENTX) in Q2 2025, closing a stake of 12,554 shares — an estimated $21.3K sold.

Two Sigma Securities first reported a position in ENTX in Q4 2023 and held it in 2 quarters. The position peaked at $41.7K in Q4 2023. 19 funds tracked by Wall St. Rank hold ENTX as of Q2 2025.

Two Sigma Securities reported no remaining Entera Bio position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 12,554 Entera Bio shares in Q2 2025, an estimated $21.3K.
Two Sigma Securities first reported a position in Entera Bio in Q4 2023 and held it in 2 quarters.
Two Sigma Securities's Entera Bio position peaked at $41.7K in Q4 2023.
19 funds tracked by Wall St. Rank held Entera Bio as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.